BR0317564A - Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos - Google Patents

Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos

Info

Publication number
BR0317564A
BR0317564A BR0317564-2A BR0317564A BR0317564A BR 0317564 A BR0317564 A BR 0317564A BR 0317564 A BR0317564 A BR 0317564A BR 0317564 A BR0317564 A BR 0317564A
Authority
BR
Brazil
Prior art keywords
compositions
methods
compounds
fungal diseases
treating bacterial
Prior art date
Application number
BR0317564-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Ving Lee
Stephen J Benkovic
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BR0317564A publication Critical patent/BR0317564A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0317564-2A 2002-12-18 2003-12-18 Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos BR0317564A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43437502P 2002-12-18 2002-12-18
US43609502P 2002-12-23 2002-12-23
US43784903P 2003-01-03 2003-01-03
PCT/US2003/040982 WO2004056322A2 (en) 2002-12-18 2003-12-18 Antibiotics containing borinic acid complexes and methods of use

Publications (1)

Publication Number Publication Date
BR0317564A true BR0317564A (pt) 2005-11-22

Family

ID=32686073

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317564-2A BR0317564A (pt) 2002-12-18 2003-12-18 Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos

Country Status (11)

Country Link
US (2) US20040224923A1 (enExample)
EP (2) EP1581500A4 (enExample)
JP (2) JP2006511613A (enExample)
KR (1) KR20050084378A (enExample)
CN (1) CN101928295A (enExample)
AU (1) AU2003299821B2 (enExample)
BR (1) BR0317564A (enExample)
CA (1) CA2509645A1 (enExample)
MX (1) MXPA05006685A (enExample)
NZ (1) NZ540870A (enExample)
WO (1) WO2004056322A2 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325504C (zh) 2002-01-10 2007-07-11 宾夕法尼亚州研究基金会 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
MXPA05006685A (es) * 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.
AR049916A1 (es) * 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Usos anti-parasitarios de complejos de acido borinico
AR049915A1 (es) * 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
EP1765360B1 (en) 2004-06-14 2009-11-11 Anacor Pharmaceuticals, Inc. Anti-viral uses of borinic acid complexes
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
ES2872962T3 (es) 2005-02-16 2021-11-03 Anacor Pharmaceuticals Inc Boronoftalidas para uso terapéutico
MX2007011486A (es) * 2005-03-24 2007-11-20 Anacor Pharmaceuticals Inc Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.
EP1965647A2 (en) * 2005-12-28 2008-09-10 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
RU2642628C2 (ru) 2006-02-16 2018-01-25 Анакор Фармасьютикалз, Инк. Бор-содержащие малые молекулы в качестве противовоспалительных средств
US20070286822A1 (en) * 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
BRPI0713010A2 (pt) * 2006-06-12 2012-10-09 Anacor Pharmaceuticals Inc compostos para o tratamento de doença periodontal
EP2069370A4 (en) * 2006-11-22 2011-05-04 Anacor Pharmaceuticals Inc MICRO-ORGANISMS KILLING COMPOUNDS
EP3246034A1 (en) 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
US20100256092A1 (en) * 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010027975A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
SG172040A1 (en) * 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
EP2458995A1 (en) 2009-07-28 2012-06-06 Anacor Pharmaceuticals, Inc. Trisubstituted boron-containing molecules
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
US20110207701A1 (en) * 2009-08-19 2011-08-25 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US8461134B2 (en) * 2009-11-11 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011116348A1 (en) 2010-03-19 2011-09-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agent
DK2613788T3 (en) 2010-09-07 2017-08-07 Anacor Pharmaceuticals Inc BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
AR094666A1 (es) 2013-01-30 2015-08-19 Dow Agrosciences Llc Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
BR112016003692B1 (pt) * 2013-08-20 2022-02-08 3M Innovative Properties Company Complexo poliéter boro-silano
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
IL248150B (en) 2016-09-29 2018-05-31 Garti Nissim Method for selective extraction of cannabinoids from a plant source
IL248149B (en) 2016-09-29 2020-03-31 Garti Nissim Dilutable formulations of cannbinoids and processes for their preparation
EP3522892A4 (en) * 2016-10-05 2020-05-13 The Global Alliance for TB Drug Development, Inc. HETEROARYL TRIFLUORBORATE COMPOUNDS FOR TREATING MYCOBACTERIAL INFECTIONS
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
CA3054138A1 (en) * 2017-03-09 2018-09-13 The Penn State Research Foundation Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase
EP3840637B1 (en) * 2018-08-20 2025-08-06 Senseonics, Incorporated Mediated drug release for reducing in vivo analyte indicator degradation
WO2022043936A1 (en) 2020-08-31 2022-03-03 Pfizer Inc. Methods of protecting rna
US12357552B2 (en) 2021-03-09 2025-07-15 Juris GERMANAS Hydroxyquinoline compounds and methods of use as pigment modifying agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0496757B1 (de) * 1989-10-18 1995-07-12 Hoechst Schering AgrEvo GmbH Verfahren zur bekämpfung von schadpflanzen in reis
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5348948A (en) * 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
JPH0952893A (ja) * 1995-08-10 1997-02-25 Yoshitomi Pharmaceut Ind Ltd キノロンカルボン酸誘導体の工業的な製造法およびその合成中間体
DE19829947A1 (de) * 1998-07-04 2000-01-05 Bayer Ag Elektrolumineszierende Anordnungen mit Bor-Chelaten
EP1155698A4 (en) * 1999-01-29 2003-01-15 Nitto Kasei Co Ltd ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY
CN1370170A (zh) * 1999-05-25 2002-09-18 宾夕法尼亚州研究基金会 Dna甲基转移酶抑制剂
DE10110051C2 (de) * 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
JP2002322007A (ja) * 2001-04-27 2002-11-08 Shionogi & Co Ltd 有機ホウ素化合物を含有する植物用殺線虫剤
CN1325504C (zh) * 2002-01-10 2007-07-11 宾夕法尼亚州研究基金会 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
MXPA05006685A (es) * 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
US20040224923A1 (en) 2004-11-11
EP1980564A1 (en) 2008-10-15
AU2003299821A1 (en) 2004-07-14
NZ540870A (en) 2008-09-26
EP1581500A2 (en) 2005-10-05
CA2509645A1 (en) 2004-07-08
EP1581500A4 (en) 2008-03-05
MXPA05006685A (es) 2005-12-14
KR20050084378A (ko) 2005-08-26
WO2004056322A3 (en) 2004-09-16
WO2004056322A2 (en) 2004-07-08
CN101928295A (zh) 2010-12-29
US20080146803A1 (en) 2008-06-19
AU2003299821B2 (en) 2010-02-18
JP2009161540A (ja) 2009-07-23
JP2006511613A (ja) 2006-04-06

Similar Documents

Publication Publication Date Title
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
TW200612939A (en) Antibiotics containing borinic acid complexes and methods of use
SG149043A1 (en) N,n-dihalogenated amino acids and derivatives
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
TW200612966A (en) Boron-containing compounds and methods of use
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
WO2005092304A3 (en) Antifungal agents
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
PT1765360E (pt) Utilizações antivirais de complexos de ácido borínico
TW200602295A (en) Organic compounds
WO2004043928A3 (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
AU2002223796A1 (en) Pleuromutilin derivatives with antimicrobial activity
WO2007125383A3 (en) Topical drug delivery by iontophoresis
WO2003024996A3 (de) Antibakterielle makrozyklen
TW200610530A (en) Anti-parasitic uses of borinic acid complexes
WO2002055022A3 (en) Active metabolite of antifungal compound
BG104259A (bg) Производни на 4-циано-4-деформилсордарицин
MXPA06000137A (es) Mezclas fungicidas.
WO2005053613A3 (en) Combinations for the treatment of fungal infections
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
WO2000041473A3 (de) Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen
WO2008107398A3 (en) Pyrazine compounds
AP2001002164A0 (en) Use of phosphonoformic acid derivatives for treating infections.
NO20055998L (no) Diarylmetylidenpiperidinderivater, preparater derav og anvendelse derav

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.